Procrit Shows Benefits Over Aranesp In Anemia Patient Study
Executive Summary
Cancer patients with chemotherapy-induced anemia who are treated with Procrit (epoetin alfa) experience a higher increase in hemoglobin levels than those treated with Aranesp (darbepoetin alfa), according to a study in the September issue of The Oncologist.